{
    "2019-01-13": [
        [
            {
                "time": "2018-12-31",
                "original_text": "Here's Why Eli Lilly Stock Surged 37% in 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Surged",
                        "37%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Conferences",
                        "PDUFA Dates",
                        "Clinical Trials"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
                "features": {
                    "keywords": [
                        "Loxo Oncology",
                        "Soared",
                        "66.4%",
                        "Another 66%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "oncology",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since",
                "features": {
                    "keywords": [
                        "Loxo Oncology",
                        "Soared",
                        "66.4%",
                        "Another 66%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "oncology",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}